Cargando…
Tamoxifen in breast cancer survivors with COVID 19: stop or go?
| Autores principales: | , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2021
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966904/ https://www.ncbi.nlm.nih.gov/pubmed/33730224 http://dx.doi.org/10.1007/s12032-021-01492-z |
| _version_ | 1783665761630289920 |
|---|---|
| author | Karacin, Cengiz Karacin, Pinar Ergun, Yakup |
| author_facet | Karacin, Cengiz Karacin, Pinar Ergun, Yakup |
| author_sort | Karacin, Cengiz |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-7966904 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2021 |
| publisher | Springer US |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-79669042021-03-17 Tamoxifen in breast cancer survivors with COVID 19: stop or go? Karacin, Cengiz Karacin, Pinar Ergun, Yakup Med Oncol Letter to the Editor Springer US 2021-03-17 2021 /pmc/articles/PMC7966904/ /pubmed/33730224 http://dx.doi.org/10.1007/s12032-021-01492-z Text en © Springer Science+Business Media, LLC, part of Springer Nature 2021 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
| spellingShingle | Letter to the Editor Karacin, Cengiz Karacin, Pinar Ergun, Yakup Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title | Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title_full | Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title_fullStr | Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title_full_unstemmed | Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title_short | Tamoxifen in breast cancer survivors with COVID 19: stop or go? |
| title_sort | tamoxifen in breast cancer survivors with covid 19: stop or go? |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7966904/ https://www.ncbi.nlm.nih.gov/pubmed/33730224 http://dx.doi.org/10.1007/s12032-021-01492-z |
| work_keys_str_mv | AT karacincengiz tamoxifeninbreastcancersurvivorswithcovid19stoporgo AT karacinpinar tamoxifeninbreastcancersurvivorswithcovid19stoporgo AT ergunyakup tamoxifeninbreastcancersurvivorswithcovid19stoporgo |